These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 8672169)

  • 1. The irreversible gamma-aminobutyrate transaminase inhibitor vigabatrin in the treatment of the alcohol withdrawal syndrome.
    Stuppaeck CH; Deisenhammer EA; Kurz M; Whitworth AB; Hinterhuber H
    Alcohol Alcohol; 1996 Jan; 31(1):109-11. PubMed ID: 8672169
    [No Abstract]   [Full Text] [Related]  

  • 2. [Acute psychosis and vigabatrin in childhood].
    Chiaretti A; Castorina M; Tortorolo L; Piastra M; Polidori G
    Pediatr Med Chir; 1994; 16(5):489-90. PubMed ID: 7885961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Status epilepticus during vigabatrin treatment: a report of three cases.
    de Krom MC; Verduin N; Visser E; Kleijer M; Scholtes F; De Groen JH
    Seizure; 1995 Jun; 4(2):159-62. PubMed ID: 7670770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe persistent visual field constriction associated with vigabatrin.
    Eke T; Talbot JF; Lawden MC
    BMJ; 1997 Jan; 314(7075):180-1. PubMed ID: 9022432
    [No Abstract]   [Full Text] [Related]  

  • 5. [The usefulness of statistical tests in publications].
    Roubergue A; Schlumberger ME; Billette de Villemeur T
    Arch Pediatr; 1999 May; 6(5):587-9. PubMed ID: 10370819
    [No Abstract]   [Full Text] [Related]  

  • 6. The new anti-epileptic drugs.
    Murphy R
    Ir Med J; 1995; 88(6):198-9. PubMed ID: 8575915
    [No Abstract]   [Full Text] [Related]  

  • 7. Vigabatrin-associated reversible acute psychosis in a child.
    Cánovas Martínez A; Ordovás Baines JP; Beltrán Marqués M; Escrivá Aparisi A; Delgado Cordón F
    Ann Pharmacother; 1995 Nov; 29(11):1115-7. PubMed ID: 8573955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vigabatrin for startle-disease with altered cerebrospinal-fluid free gamma-aminobutyric acid.
    Stephenson JB
    Lancet; 1992 Aug; 340(8816):430-1. PubMed ID: 1353584
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment with vigabatrin may mimic alpha-aminoadipic aciduria.
    Vallat C; Rivier F; Bellet H; Magnan de Bornier B; Mion H; Echenne B
    Epilepsia; 1996 Aug; 37(8):803-5. PubMed ID: 8764822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Symptomatic and asymptomatic visual loss in patients taking vigabatrin.
    Daneshvar H; Racette L; Coupland SG; Kertes PJ; Guberman A; Zackon D
    Ophthalmology; 1999 Sep; 106(9):1792-8. PubMed ID: 10485552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Vigabatrin and lamotrigin: experiences with 2 new anticonvulsants in the Swiss epilepsy clinic].
    Vogt H; Krämer G
    Schweiz Med Wochenschr; 1995 Jan; 125(4):125-32. PubMed ID: 7878401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vigabatrin in partial seizures in children.
    Nabbout RC; Chiron C; Mumford J; Dumas C; Dulac O
    J Child Neurol; 1997 Apr; 12(3):172-7. PubMed ID: 9130090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measuring human brain GABA in vivo: effects of GABA-transaminase inhibition with vigabatrin.
    Petroff OA; Rothman DL
    Mol Neurobiol; 1998 Feb; 16(1):97-121. PubMed ID: 9554704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seizures in a boy with succinic semialdehyde dehydrogenase deficiency treated with vigabatrin (gamma-vinyl-GABA).
    Matern D; Lehnert W; Gibson KM; Korinthenberg R
    J Inherit Metab Dis; 1996; 19(3):313-8. PubMed ID: 8803774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [New drugs in the treatment of childhood epilepsy: vigabatrin (study of 61 subjects)].
    Raucci U; Spalice A; Basile LA; Guardalà C; Nasta L; Terenzi S; Iannetti P
    Pediatr Med Chir; 1994; 16(6):575-8. PubMed ID: 7708543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A risk-benefit assessment of vigabatrin in the treatment of neurological disorders.
    Srinivasan J; Richens A
    Drug Saf; 1994 May; 10(5):395-405. PubMed ID: 8037889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vigabatrin versus carbamazepine and phenytoin in kainic acid-treated pubescent rats.
    Mecarelli O; De Feo MR; Del Priore D
    Pharmacol Res; 1997 Aug; 36(2):87-93. PubMed ID: 9344635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vigabatrin therapy in six patients with succinic semialdehyde dehydrogenase deficiency.
    Gibson KM; Jakobs C; Ogier H; Hagenfeldt L; Eeg-Olofsson KE; Eeg-Olofsson O; Aksu F; Weber HP; Rossier E; Vollmer B
    J Inherit Metab Dis; 1995; 18(2):143-6. PubMed ID: 7564230
    [No Abstract]   [Full Text] [Related]  

  • 19. Recommendations for visual evaluations of patients treated with vigabatrin.
    Sergott RC
    Curr Opin Ophthalmol; 2010 Nov; 21(6):442-6. PubMed ID: 20811279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vigabatrin causes profound reduction in serum alanine transaminase activity.
    Ryan MF; Samy A; Young J
    Ann Clin Biochem; 1996 May; 33 ( Pt 3)():257-8. PubMed ID: 8791991
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.